0001600132-20-000098.txt : 20200914
0001600132-20-000098.hdr.sgml : 20200914
20200914160222
ACCESSION NUMBER: 0001600132-20-000098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200914
DATE AS OF CHANGE: 20200914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amin Naseem
CENTRAL INDEX KEY: 0001646754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 201173200
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD, SUITE 301
CITY: HAMPTON
STATE: NJ
ZIP: 08827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
wf-form4_160011372674653.xml
FORM 4
X0306
4
2020-09-10
0
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001646754
Amin Naseem
C/O BELLEROPHON THERAPEUTICS, INC.
184 LIBERTY CORNER ROAD, SUITE 302
WARREN
NJ
07059
1
0
0
0
Stock Option (right to buy)
10.12
2020-09-10
4
A
0
6509
10.12
A
2021-09-10
2030-09-10
Common Stock
6509.0
15138
D
/s/ Naseem Amin
2020-09-14